Table of Contents 3
List of Tables 5
List of Figures 5
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NicOx SA, Medical Devices Deals, 2012 to YTD 2018 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NicOx SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13
Venture Financing 15
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 15
Private Equity 16
GHO Capital Partners Acquires European and International Commercial Operations of Nicox 16
Partnerships 18
Nicox Enters into Research Collaboration Agreement with Ironwood Pharma 18
Nicox Enters into Agreement with Ironwood Pharma 19
Nicox and Re-Vana Therapeutics Enter into Research Agreement 20
pSivida and Nicox Enter into Agreement 21
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 22
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 23
Aciex Amends Research Agreement With Portola Pharma 24
Licensing Agreements 25
Eyevance Pharma Enters into Licensing Agreement with Nicox Opthalmics 25
Ora Enters into Licensing Agreement with Nicox Ophthalmics 26
Fera Pharma Amends Licensing Agreement with Nicox 27
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 28
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 29
Equity Offering 30
Nicox Files Draft Registration Statement for American Depository Shares 30
NicOx Raises USD31 Million in Private Placement of Shares 31
Nicox to Raise USD20 Million in Private Placement of Shares 32
Nicox Raises USD29.8 Million in Private Placement of Shares 33
Acquisition 34
Valeant Pharma Acquires Nicox for USD20 Million 34
NicOx Acquires Aciex Therapeutics 35
NicOx Acquires Doliage for USD6.5 Million 36
NicOx Completes Acquisition Of Eupharmed For US$8 Million 37
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 39
NicOx SA - Key Competitors 41
NicOx SA - Key Employees 42
NicOx SA - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 44
Strategy And Business Planning 44
Apr 25, 2018: Nicox: Opening of U.S. Development Office in Research Triangle Park, North Carolina 44
Financial Announcements 45
Sep 06, 2018: Nicox first half 2018 financial results and business update 45
Jul 17, 2018: Nicox announces second quarter 2018 financial results 47
May 04, 2018: Nicox Provides First Quarter 2018 Business and Financial Results 49
Sep 08, 2017: Nicox first half 2017 business and financial update 50
Apr 27, 2017: Nicox first quarter 2017 business update and cash position 51
Mar 31, 2017: Nicox: Business Update and 2016 Financial Results 52
Corporate Communications 54
Jan 03, 2018: Nicox Appoints Tomas Navratil, Ph.D., as Head of Development 54
May 17, 2017: Mrs. Lauren P. Silvernail appointed to Nicox Board of Directors 55
May 17, 2017: Ms. Lauren P. Silvernail appointed to Nicox Board of Directors 56
Clinical Trials 57
May 09, 2017: Nicox announces the presentation of scientific data on NCX 667 at ARVO 2017 57
Feb 21, 2017: Nicox announces the presentation of NCX 667 scientific data at AOPT 2017 58
Jan 24, 2017: Nicox provides clinical and regulatory update for NCX 470 for IOP lowering 59
Jan 05, 2017: Nicox provides clinical and regulatory update for NCX 4251 in blepharitis 60
Other Significant Developments 61
Mar 06, 2018: Nicox provides 2018 Outlook and 2017 Estimated Financial Results 61
Dec 19, 2017: Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA and Outlines 2018 Activities 63
Oct 24, 2017: Nicox Provides Third Quarter 2017 Business Update and Cash Position 65
Sep 08, 2017: Nicox first half 2017 business and financial update 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
NicOx SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NicOx SA, Deals By Therapy Area, 2012 to YTD 2018 9
NicOx SA, Medical Devices Deals, 2012 to YTD 2018 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 15
GHO Capital Partners Acquires European and International Commercial Operations of Nicox 16
Nicox Enters into Research Collaboration Agreement with Ironwood Pharma 18
Nicox Enters into Agreement with Ironwood Pharma 19
Nicox and Re-Vana Therapeutics Enter into Research Agreement 20
pSivida and Nicox Enter into Agreement 21
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 22
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 23
Aciex Amends Research Agreement With Portola Pharma 24
Eyevance Pharma Enters into Licensing Agreement with Nicox Opthalmics 25
Ora Enters into Licensing Agreement with Nicox Ophthalmics 26
Fera Pharma Amends Licensing Agreement with Nicox 27
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 28
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 29
Nicox Files Draft Registration Statement for American Depository Shares 30
NicOx Raises USD31 Million in Private Placement of Shares 31
Nicox to Raise USD20 Million in Private Placement of Shares 32
Nicox Raises USD29.8 Million in Private Placement of Shares 33
Valeant Pharma Acquires Nicox for USD20 Million 34
NicOx Acquires Aciex Therapeutics 35
NicOx Acquires Doliage for USD6.5 Million 36
NicOx Completes Acquisition Of Eupharmed For US$8 Million 37
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 39
NicOx SA, Key Competitors 41
NicOx SA, Key Employees 42
NicOx SA, Subsidiaries 43

List of Figures
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NicOx SA, Medical Devices Deals, 2012 to YTD 2018 10